News: Search results for "Merck "

» 3 results in Specials» 4 results in World» 3 results in Business
» 1 results in Science» 80 results in Health 
dotclear

News: Specials

Byetta Outruns Rival Januvia in Diabetes Trial

Byetta Outruns Rival Januvia in Diabetes Trial

Eli Lilly and Co and Amylin Pharmaceuticals Inc’s diabetes drug Byetta proved better at reducing...
» read full story September 10th, 2008 - 15:20
Update: FDA Reveals List Of Drugs Posing Health Risks

Update: FDA Reveals List Of Drugs Posing Health Risks

The US Food and Drug Administration is planning to raise awareness on possible side effects of...
» read full story September 08th, 2008 - 14:00
What Do Mothers Think About Gardasil Vaccine?

What Do Mothers Think About Gardasil Vaccine?

A team of researchers has discovered that mothers' conceptions regarding sex before marriage don't...
» read full story August 24th, 2008 - 19:47
dotclear

News: World

US Delays the Delivery of AIDS Vaccine

US Delays the Delivery of AIDS Vaccine

On Thursday, federal researchers gave up on their plans to carry out the large scale experimental...
» read full story July 19th, 2008 - 14:38
EU Backs Erbitux as First Line Drug Against Cancer

EU Backs Erbitux as First Line Drug Against Cancer

The European Medicines Agency, based in London, has approved the use of Erbitux, produced by Merck...
» read full story June 02nd, 2008 - 11:07
Two Expensive Cholesterol Drugs May Be Ineffective

Two Expensive Cholesterol Drugs May Be Ineffective

U.S. spent $1.5 billion in 2006 on Vytorin, a cholesterol drug that actually does not work better...
» read full story March 31st, 2008 - 15:03
Outbreak of Foot-and-Mouth Linked to Laboratory

Outbreak of Foot-and-Mouth Linked to Laboratory

The outbreak of foot-and-mouth disease in Surrey, Britain could be linked to a laboratory located...
» read full story August 05th, 2007 - 14:03
dotclear

News: Business

Vytorin Sales Drop for Schering and Merck, Due to Ineffectiveness

Shares of Merck and Schering-Plough dropped greatly on Monday, after a research revealed that the...
» read full story March 31st, 2008 - 17:11
Merck Offers 4.85 Billion Dollars To Settle Vioxx Cases

Merck Offers 4.85 Billion Dollars To Settle Vioxx Cases

The US drug maker Merck & Co announced on Friday it will pay 4,85 billion dollars to settle...
» read full story November 10th, 2007 - 14:26
Medco Health to Acquire PolyMedica for $1.5B

Medco Health to Acquire PolyMedica for $1.5B

Medco Health Solutions Inc. announced it is to acquire the largest U.S. supplier of diabetes...
» read full story August 29th, 2007 - 14:43
dotclear

News: Science

Large Human Trial Of HIV Vaccine Canceled By NIAID

Large Human Trial Of HIV Vaccine Canceled By NIAID

The National Institutes of Health on Thursday canceled a US human trial of a human...
» read full story July 21st, 2008 - 08:13
dotclear

News: Health

One Quarter of United States Teen Girls Received HPV Vaccine

One Quarter of United States Teen Girls Received HPV Vaccine

On Thursday, federal health officials informed that 25 percent of teen girls in the United States...
» read full story October 10th, 2008 - 21:13
Report: 25 Percent Of US Teen Girls Got Cervical Cancer Vaccine In 2007

Report: 25 Percent Of US Teen Girls Got Cervical Cancer Vaccine In 2007

However controversial Merck’s cervical cancer vaccine Gardasil has been considered since approval,...
» read full story October 10th, 2008 - 14:13
German Farmer Recovering Well after Double Arm Transplant

German Farmer Recovering Well after Double Arm Transplant

A 54-year old German farmer received the world’s first complete double arm transplant at the...
» read full story October 09th, 2008 - 14:30
Pfizer Tampered With Neurontin Studies, Lawsuit Claims

Pfizer Tampered With Neurontin Studies, Lawsuit Claims

Another page is written these days in the scandal around pharmaceutical companies paying good...
» read full story October 08th, 2008 - 15:08
Merck’s Discontinuation On Taranabant Development

Merck’s Discontinuation On Taranabant Development

Merck & Co. has decided to bring to an end the development the experimental obesity drug...
» read full story October 05th, 2008 - 16:16
Leading Emory Psychiatrist ‘Fails’ to Report $1.2 Million of Drug Income

Leading Emory Psychiatrist ‘Fails’ to Report $1.2 Million of Drug Income

Emory University psychiatrist Charles Nemeroff has been accused of not reporting almost half of the...
» read full story October 04th, 2008 - 19:54
Merck Cancels Further Examination into Its Experimental Obesity Drug Taranabant

Merck Cancels Further Examination into Its Experimental Obesity Drug Taranabant

Merck & Co. on Thursday announced its decision to cancel further investigation into its...
» read full story October 03rd, 2008 - 16:30
Farewell To Development Of Obesity Drug Taranabant

Farewell To Development Of Obesity Drug Taranabant

Merck halted the research of the experimental obesity drug taranabant because of the dangerous side...
» read full story October 03rd, 2008 - 14:01
FDA Study: Statins Don’t Pose Risk Of Lou Gehrig’s Disease

FDA Study: Statins Don’t Pose Risk Of Lou Gehrig’s Disease

Cholesterol-lowering drugs or statins do not increase the incidence of amyotrophic lateral...
» read full story September 30th, 2008 - 14:30
New Osteoporosis Drug, Amgen’s Denosumab, Reaches Market

New Osteoporosis Drug, Amgen’s Denosumab, Reaches Market

Amgen’s experimental bone drug, called denosumab, was found to reduce the risk of spinal fractures...
» read full story September 19th, 2008 - 15:30
Amgen To Release Data On Its Experimental Osteoporosis Drug Denosumab

Amgen To Release Data On Its Experimental Osteoporosis Drug Denosumab

Biotechnology company Amgen Inc. will release the results of the study on its osteoporosis drug...
» read full story September 16th, 2008 - 15:44
Merck & Co.’s Vaccine Gardasil Approved for Vaginal, Vulvar Cancer

Merck & Co.’s Vaccine Gardasil Approved for Vaginal, Vulvar Cancer

The Food and Drug Administration on Friday approved Merck & Co.’s cervical cancer vaccine...
» read full story September 15th, 2008 - 15:15

This Year’s Lasker Awards for Medical Research: Top Five

Akira Endo, a Japanese scientist who discovered the first cholesterol-lowering statin drug, was...
» read full story September 15th, 2008 - 14:00
Five Renowned Researchers Honored with This Year’s Lasker Awards

Five Renowned Researchers Honored with This Year’s Lasker Awards

Akira Endo, 74, of Biopharm Research Laboratories in Tokyo was one of the five scientists awarded...
» read full story September 14th, 2008 - 14:13
Gardasil Fights Against Vulvar And Vaginal Cancers

Gardasil Fights Against Vulvar And Vaginal Cancers

The FDA has updated the label of Gardasil, the cervical cancer vaccine manufactured by Merck,...
» read full story September 13th, 2008 - 17:25
Gardasil Gets FDA Approval for Two Types of Cancer

Gardasil Gets FDA Approval for Two Types of Cancer

Friday, the Food and Drug Administration informed that Merck’s Gardasil vaccine, which prevents...
» read full story September 13th, 2008 - 13:56
Gardasil Proven Effective In Two Other Type Of Cancers

Gardasil Proven Effective In Two Other Type Of Cancers

FDA approved on Friday the use of Gardasil vaccine in fighting vaginal and vulvar cancers, in...
» read full story September 13th, 2008 - 11:33
Update: Pfizer Is Seeking FDA’s Approval For Osteoporosis Drug

Update: Pfizer Is Seeking FDA’s Approval For Osteoporosis Drug

Pfizer, the world’s biggest drugmaker, is seeking U.S. Food and Drug Administration approval for...
» read full story September 09th, 2008 - 14:30
Pfizer’s Osteoporosis Treatment Under FDA Analysis

Pfizer’s Osteoporosis Treatment Under FDA Analysis

Today, Pfizer Incorporated appeared for the third time before Federal Drug Administration medical...
» read full story September 08th, 2008 - 23:12
Update: Debate Over Link Between Vytorin And Cancer

Update: Debate Over Link Between Vytorin And Cancer

When the FDA approved Vytorin, a medicine that lowers bad cholesterol in the blood and raises the...
» read full story September 04th, 2008 - 11:50
Experts at Odds over Vytorin's Alleged Cancer Risk

Experts at Odds over Vytorin's Alleged Cancer Risk

Vytorin prescriptions drop as studies link the cholesterol drug with higher numbers of cancer...
» read full story September 02nd, 2008 - 20:54
Merck & Co.’s HPV Vaccine Gardasil Safe despite Allergic Reactions

Merck & Co.’s HPV Vaccine Gardasil Safe despite Allergic Reactions

Gardasil, the cervical cancer vaccine developed by Merck & Co. which protects against the...
» read full story September 02nd, 2008 - 16:06
Study Finds No Evidence To Support Link Between Singulair And Suicide

Study Finds No Evidence To Support Link Between Singulair And Suicide

U.S. researchers re-examined data from patients who had taken part in Singulair trials, in order to...
» read full story September 02nd, 2008 - 14:53
Vytorin’s  Effectiveness Questioned, Debate over Cancer Risk Continues

Vytorin’s Effectiveness Questioned, Debate over Cancer Risk Continues

The debate over Vytorin’s cancer risk continues as results of a controversial Vytorin study,...
» read full story September 02nd, 2008 - 14:23
Study Concludes that HPV Vaccine Is Less Effective with Age

Study Concludes that HPV Vaccine Is Less Effective with Age

According to the findings of a new study, Merck & Co.'s Gardasil (vaccine against cervical...
» read full story August 25th, 2008 - 16:24
Study Finds that Vytorin Might Cause Cancer

Study Finds that Vytorin Might Cause Cancer

The Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial found out that the drug Vytorin, used...
» read full story August 24th, 2008 - 19:59
Cervical Cancer Vaccine Might Be Cost-Effective If Administered to Preteens

Cervical Cancer Vaccine Might Be Cost-Effective If Administered to Preteens

A study carried out at the Harvard School of Public Health discovered that cervical cancer vaccine...
» read full story August 23rd, 2008 - 16:54
Vytorin's Alleged Cancer Risk Questioned by FDA, Experts

Vytorin's Alleged Cancer Risk Questioned by FDA, Experts

Earlier this year, it was revealed that the U.S. spent $1.5 billion in 2006 on Vytorin, a...
» read full story August 22nd, 2008 - 16:41

FDA to Review Vytorin for Possible Cancer Risk

A recent study on cholesterol-lowering drug Vytorin, called SEAS, linking it to an increased risk...
» read full story August 22nd, 2008 - 14:00
Merck’s Cervical Cancer Vaccine - Cost Inefficacious For Adult Women

Merck’s Cervical Cancer Vaccine - Cost Inefficacious For Adult Women

On Wednesday, the findings of a new cervical cancer oriented study, conducted by researchers of the...
» read full story August 21st, 2008 - 15:01
Merck’s Cervical Cancer Vaccine Doesn’t Justify Cost in Adult Women

Merck’s Cervical Cancer Vaccine Doesn’t Justify Cost in Adult Women

Merck & Co.’s Gardasil cervical cancer vaccine faces serious doubts when it comes to its...
» read full story August 21st, 2008 - 13:15
Merck’s Study on Vioxx Had Marketing Purposes, Not Scientific

Merck’s Study on Vioxx Had Marketing Purposes, Not Scientific

A report appeared in the August 19 issue of the Annals of Internal Medicine reveals that a 1999...
» read full story August 19th, 2008 - 14:30
FDA Issues Warning On Cholesterol – Heart Drug Interaction

FDA Issues Warning On Cholesterol – Heart Drug Interaction

<!-- /* Style Definitions */ p.MsoNormal, li.MsoNormal,...
» read full story August 09th, 2008 - 13:39
Antiretroviral Therapy Adds 13 Years More for HIV Patients

Antiretroviral Therapy Adds 13 Years More for HIV Patients

New research published in this week’s special HIV/AIDS issue of The Lancet reveals that the life...
» read full story July 25th, 2008 - 12:00
Genetic Variation Linked To Muscle Pain Due To Statins

Genetic Variation Linked To Muscle Pain Due To Statins

A genetic variation might be responsible for a rare but serious side effect of...
» read full story July 24th, 2008 - 15:05
AIDS Vaccine Testing Delayed, Not Cancelled

AIDS Vaccine Testing Delayed, Not Cancelled

Although last week the National Institute of Allergy and Infectious Diseases (NIAID) gave up on its...
» read full story July 22nd, 2008 - 15:43
Large Human Trial Of HIV Vaccine Canceled

Large Human Trial Of HIV Vaccine Canceled

The National Institutes of Health on Thursday canceled a US human trial of a human...
» read full story July 18th, 2008 - 13:20
Gardasil’s Safety Questioned

Gardasil’s Safety Questioned

Two years ago, Merck & Co. got approval for its Gardasil, the first cervical cancer vaccine to...
» read full story July 09th, 2008 - 14:02
AAP Makes Controversial Recommendations for Statin Use in Kids

AAP Makes Controversial Recommendations for Statin Use in Kids

The American Academy of Pediatrics has changed its guidelines, recommending testing of overweight...
» read full story July 08th, 2008 - 17:55
Glaxo’s Cervical Cancer Vaccine, Cervarix, Delayed US Approval

Glaxo’s Cervical Cancer Vaccine, Cervarix, Delayed US Approval

GlaxoSmithKline, the second biggest pharmaceutical company in the world, announced on Monday that...
» read full story July 01st, 2008 - 14:10
Gardasil Use Denied in Older Women

Gardasil Use Denied in Older Women

The U.S. Food and Drug Administration denied Merck & Co Inc.’s request to market its...
» read full story June 26th, 2008 - 14:33
CDC Adds Glaxo’s Rotavirus Vaccine After Merck’s Proves Efficient

CDC Adds Glaxo’s Rotavirus Vaccine After Merck’s Proves Efficient

The U.S. Centers for Disease Control and Prevention on Wednesday recommended...
» read full story June 26th, 2008 - 10:26
Bristol‘s Diabetes Drug Proves Efficient in Controlling Sugar

Bristol‘s Diabetes Drug Proves Efficient in Controlling Sugar

Experimental drug, saxagliptin from Bristol-Myers Squibb Co. and AstraZeneca proved efficient in...
» read full story June 07th, 2008 - 21:13
New Data Triggers Revision of Erbitrux vs. Avastin Study

New Data Triggers Revision of Erbitrux vs. Avastin Study

While the European Medicines Agency, based in London, has approved the use of Erbitux, produced by...
» read full story June 04th, 2008 - 22:37
Erbitux Boosts Survival in Lung Cancer Patients

Erbitux Boosts Survival in Lung Cancer Patients

Results of a long awaited clinical trial of ImClone Systems Inc's Erbitux, called Flex, give hopes...
» read full story June 01st, 2008 - 08:50
EU Backs Merck KGaA’s Erbitux for First-Line Use

EU Backs Merck KGaA’s Erbitux for First-Line Use

Germany’s Merck KGaA announced Friday that Erbitux, which it licensed from ImClone System Inc and...
» read full story May 31st, 2008 - 08:20
Family History Adds to People’s Risk of Developing Shingles

Family History Adds to People’s Risk of Developing Shingles

Just days after the U.S. Centers for Disease Control and Prevention recommended that people aged...
» read full story May 20th, 2008 - 16:26
CDC: People over 60 Should Get Shingles Vaccine

CDC: People over 60 Should Get Shingles Vaccine

The U.S. Centers for Disease Control and Prevention recommended on Thursday that people aged 60...
» read full story May 16th, 2008 - 12:09
Osteoporosis Drug Fosamax Doubles Atrial Fibrillation Risk

Osteoporosis Drug Fosamax Doubles Atrial Fibrillation Risk

Women following treatment with bisphosphonate alendronate (Fosamax) for their osteoporosis...
» read full story April 29th, 2008 - 15:52
Merck Faces Criticism for Unorthodox Methods in Vioxx Promotion

Merck Faces Criticism for Unorthodox Methods in Vioxx Promotion

Two studies appearing today in the Journal of the American Medical Association have prompted the...
» read full story April 16th, 2008 - 10:59
Key Cardiologist Speaks About Vytorin Scandal

Key Cardiologist Speaks About Vytorin Scandal

A key cardiologist who worked with Merck and Schering-Plough on a comprehensive study on their...
» read full story April 15th, 2008 - 22:20
Glaxo’s Rotavirus Vaccine Rotarix Gets FDA Clearance

Glaxo’s Rotavirus Vaccine Rotarix Gets FDA Clearance

The U.S. Food and Drug Administration approved Thursday GlaxoSmithKline PLC’s vaccine Rotarix, for...
» read full story April 04th, 2008 - 11:21
Vytorin and Zetia Use Questioned after Release of Study’s Results

Vytorin and Zetia Use Questioned after Release of Study’s Results

Top U.S. heart doctors warned Sunday at the American College of Cardiology’s annual meeting in...
» read full story March 31st, 2008 - 11:05
US Researchers to Expand Vytorin Study

US Researchers to Expand Vytorin Study

U.S. researchers announced Friday they would expand the size of a major study involving...
» read full story March 29th, 2008 - 11:27
Merck Asthma Drug Questioned for Suicide Risk

Merck Asthma Drug Questioned for Suicide Risk

The Food and Drug Administration has said that Merck's Singulair, which is the brand name for the...
» read full story March 27th, 2008 - 21:30
Summit on AIDS Vaccine Questions the Future of AIDS Research

Summit on AIDS Vaccine Questions the Future of AIDS Research

The recent failure of the most promising HIV vaccine prompted scientists’ concern at the Summit...
» read full story March 26th, 2008 - 13:14
Merck: FDA to Speed Review on Gardasil’s Use in Adult Women

Merck: FDA to Speed Review on Gardasil’s Use in Adult Women

Drug maker Merck & Co. announced Wednesday that the U.S. Food and Drug Administration would...
» read full story March 20th, 2008 - 12:10
Studies Find Obesity Is 'the Result of Complex Networks of Genes'

Studies Find Obesity Is 'the Result of Complex Networks of Genes'

New research shows that an entire network of genes in the body is disrupted by overeating and this...
» read full story March 17th, 2008 - 17:13
HPV Vaccine, Gardasil Linked to Fewer Abnormal Pap Tests

HPV Vaccine, Gardasil Linked to Fewer Abnormal Pap Tests

Women protecting against HPV infection and cervical cancers by vaccinating with human...
» read full story March 11th, 2008 - 15:59
Medicines for Elderly More Expensive, Report Says

Medicines for Elderly More Expensive, Report Says

A new study by the American Association of Retired People (AARP) reveals that drug makers...
» read full story March 06th, 2008 - 13:35
GlaxoSmithKline’s Rotarix Closer than Ever to Hit U.S. Market

GlaxoSmithKline’s Rotarix Closer than Ever to Hit U.S. Market

A Food and Drug Administration panel has recommended GlaxoSmithKline Plc’s vaccine Rotarix for use...
» read full story February 21st, 2008 - 15:04
HPV-Related Oral Cancers Rising in Men, Researchers Say

HPV-Related Oral Cancers Rising in Men, Researchers Say

Human papillomavirus, or HPV, the leading cause of cervical cancer in women, appears to be a major...
» read full story February 04th, 2008 - 11:08
Go Red For Women

Go Red For Women

The American Heart Association's Go Red For Women Movement has gained momentum as the First Lady...
» read full story February 01st, 2008 - 21:47
FDA Delays Decision On Vytorin

FDA Delays Decision On Vytorin

The decision on Vytorin has yet to be taken, as health officials continue discussions on the...
» read full story January 26th, 2008 - 09:36
Tests Concluded: Vytorin Has No Beneficial Effects On Patients

Tests Concluded: Vytorin Has No Beneficial Effects On Patients

Trial tests for Vytorin, a cholesterol-lowering drug, have shown that the medication has...
» read full story January 15th, 2008 - 12:05
French Officials Choose Merck’s Gardasil Over GSK’s Cervarix

French Officials Choose Merck’s Gardasil Over GSK’s Cervarix

The French health officials made an announcement on Monday that they supported the use of Gardasil...
» read full story January 15th, 2008 - 11:09
Merck’s Taranabant, another Obesity Drug with Psychiatric Side Effects

Merck’s Taranabant, another Obesity Drug with Psychiatric Side Effects

Merck Research Laboratories developed a new drug, called taranabant, which helped people shed...
» read full story January 09th, 2008 - 11:35
Cervical Shot Prompts "Ouches" from Girls

Cervical Shot Prompts "Ouches" from Girls

The controversial Gardasil vaccine from Merck & Co. that prevents cervical cancer in girls has been...
» read full story January 07th, 2008 - 12:56
Glaxo’s Cervarix Could Face Two-Year Delay in the U.S.

Glaxo’s Cervarix Could Face Two-Year Delay in the U.S.

The Food and Drug Administration (FDA), Monday, requested more information from GlaxoSmithKline...
» read full story December 20th, 2007 - 16:27
Merck’s PedvaxHib Vaccine Recalled in China

Merck’s PedvaxHib Vaccine Recalled in China

Almost a tenth of 1.2 million doses of PedvaxHib vaccine, which the American drug maker Merck...
» read full story December 16th, 2007 - 11:51
Over-the-Counter Statins – Are We Ready?

Over-the-Counter Statins – Are We Ready?

Merck made a new attempt on Thursday to convince the government experts that Mevacor – an...
» read full story December 13th, 2007 - 16:44
Merck Recalls 1.2 Million Doses of Childhood Hib Vaccine

Merck Recalls 1.2 Million Doses of Childhood Hib Vaccine

Merck & Co. is recalling about 1.2 million doses of a childhood vaccine designed to protect...
» read full story December 13th, 2007 - 11:24
Merck’s Cholesterol-lowering Drug Under FDA’s Questioning

Merck’s Cholesterol-lowering Drug Under FDA’s Questioning

This Tuesday, The Food and Drug Administration released a review that agreed that Merck’s Mevacor...
» read full story December 11th, 2007 - 21:31
Possible Leak of Foot and Mouth Virus in UK Lab

Possible Leak of Foot and Mouth Virus in UK Lab

British officials said on Thursday that the foot and mouth virus may have leaked at the same...
» read full story November 23rd, 2007 - 10:37
New Study Shows MRSA Tricks Immune System

New Study Shows MRSA Tricks Immune System

A new study shows that Methicillin-resistant Staphylococcus aureus (MRSA) may trick and destroy...
» read full story November 12th, 2007 - 21:37
Merck’s AIDS Vaccine Trial Fails

Merck’s AIDS Vaccine Trial Fails

Yesterday, at a scientific meeting in Seattle, researchers announced that Merck’s AIDS vaccine is...
» read full story November 08th, 2007 - 14:39
Merck’s Gardasil Vaccine Effective for Women 24-45 Years Old

Merck’s Gardasil Vaccine Effective for Women 24-45 Years Old

The drug maker Merck provided information according to which Gardasil vaccine may be the solution...
» read full story November 05th, 2007 - 13:19
UK Government Announces HPV Immunization Program

UK Government Announces HPV Immunization Program

The National Health Service has begun assessing how many young women will enter in the Government...
» read full story October 29th, 2007 - 19:15
Merck's New HIV Drug Isentress Approved by the FDA

Merck's New HIV Drug Isentress Approved by the FDA

The US Food and Drug Administration has approved Merck's new HIV drug Isentress (raltegravir)...
» read full story October 13th, 2007 - 21:00
Merck's Promising HIV Vaccine Canceled

Merck's Promising HIV Vaccine Canceled

Merck's HIV vaccine, which has been 10 years in development, has failed in a human trial and has...
» read full story September 22nd, 2007 - 16:51
dotclear
dotclear
dotclear
Photos Gallery
dotclear
Today's Latest News
Desulforudis audaxviator Gets Us Closer To Aliens

» read full story
dotclear
Latest videos

Presidential flip-flops

Flip-flops decorated with miniature heads of U.S. Presidential candidates Barack Obama and John McCain have given...

Two more deadly bombs in Pakistan

Around 40 people have been killed in more suicide bombs attacks in Pakistan. Two suicide bombers blew themselves...

Britain's cash boost to Afghan Army

Britain's Prime Minister has promised to put more resources into training the Afghan National Army. Gordon Brown...

Mortgage rates dip, still high

U.S. mortgage rates fell last week, but rates remain high as lenders price in higher premiums for potential...

The future in frame

A new phase of converged devices appears to be upon us, judging from the technologies on display at the 2008 Playbite...


» browse all videos
dotclear